Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Chiozzini

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current Drug Targets|August 26, 2015
HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGETChiara Chiozzini, Elena Toschi
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2022
Extracellular Vesicles and Their Use as Vehicles of ImmunogensChiara Chiozzini, Barbara Ridolfi, Maurizio Federico
Pharmaceutics|June 13, 2020
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative DiseasesFlavia Ferrantelli, Chiara Chiozzini, Patrizia Leone, et al.
Retrovirology|June 14, 2014
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1Claudia Arenaccio, Chiara Chiozzini, Sandra Columba-Cabezas, et al.
Retrovirology|October 28, 2015
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1Claudia Arenaccio, Simona Anticoli, Francesco Manfredi, et al.
Current Drug Targets|May 22, 2018
Exosomes in Therapy: Engineering, Pharmacokinetics and Future ApplicationsClaudia Arenaccio, Chiara Chiozzini, Flavia Ferrantelli, et al.
Vaccines|April 3, 2021
Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and LungsFlavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, et al.
Vaccines|May 28, 2020
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Claudia Arenaccio, et al.
Cytokine & Growth Factor Reviews|January 14, 2020
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenanceEleonora Olivetta, Chiara Chiozzini, Claudia Arenaccio, et al.
Vaccines|July 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral ProteinFrancesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Drug Targets|August 26, 2015
HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGETChiara Chiozzini, Elena Toschi
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2022
Extracellular Vesicles and Their Use as Vehicles of ImmunogensChiara Chiozzini, Barbara Ridolfi, Maurizio Federico
Pharmaceutics|June 13, 2020
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative DiseasesFlavia Ferrantelli, Chiara Chiozzini, Patrizia Leone, et al.
Retrovirology|June 14, 2014
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1Claudia Arenaccio, Chiara Chiozzini, Sandra Columba-Cabezas, et al.
Retrovirology|October 28, 2015
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1Claudia Arenaccio, Simona Anticoli, Francesco Manfredi, et al.
Current Drug Targets|May 22, 2018
Exosomes in Therapy: Engineering, Pharmacokinetics and Future ApplicationsClaudia Arenaccio, Chiara Chiozzini, Flavia Ferrantelli, et al.
Vaccines|April 3, 2021
Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and LungsFlavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, et al.
Vaccines|May 28, 2020
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Claudia Arenaccio, et al.
Cytokine & Growth Factor Reviews|January 14, 2020
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenanceEleonora Olivetta, Chiara Chiozzini, Claudia Arenaccio, et al.
Vaccines|July 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral ProteinFrancesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
Pageof 4